# Lunit

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lunit

- Industry: Healthcare IT
- Headquarters: Seoul, South Korea
- Website: www.lunit.io
- Total disclosed funding: $42M
- Latest round: Series C (Dec 31, 2019)
- Investors on record: 12

## About

Founded in 2013 and based in Seoul, South Korea, Lunit Inc. operates as a provider of software solutions that utilize artificial intelligence for medical analytics. The firm provides solutions including nodule detection in chest radiography, x-ray for chest abnormalities and mammography. In August 2023, Lunit Inc. raised USD 151 million in growth capital funding from other unspecified investors. As of 2023, the company is led by its CEO Seo Beom-seok.

The company will use the August funding to upgrade products, spur R&D and global expansion, establish a corporate venture capital (CVC), hire new overseas employees, and develop biomarkers for antibody-drug conjugate (ADC) anticancer drugs.

## Funding rounds

- Series C, Dec 31, 2019, $26M — Legend Capital, InterVest, Shinhan Securities, IMM Investment, Kakao Ventures, NH Investment & Securities, LG CNS
- Series B, Jun 20, 2018, $15M — Legend Capital, InterVest, Formation8, SBVA, Kakao Ventures, Mirae Asset Venture Investment, KT Investment
- Series A, Nov 3, 2015, $1.8M — Formation8, SBVA, Kakao Ventures
- Seed, Jun 9, 2014, $0.1M — Kakao Ventures
- Seed, Apr 24, 2014 — Kakao Ventures, Korea Tech Incubator for Startup

## Investors

- Kakao Ventures (https://capitalatlas.ai/funds/kakao-ventures) — Seed, Series A, Series B, Series C
- Korea Tech Incubator for Startup — Seed
- Formation8 (https://capitalatlas.ai/funds/formation8) — Series A, Series B
- SBVA (https://capitalatlas.ai/funds/sbva) — Series A, Series B
- Legend Capital — Series B, Series C
- InterVest (https://capitalatlas.ai/funds/intervest) — Series B, Series C
- Mirae Asset Venture Investment (https://capitalatlas.ai/funds/mirae-asset-venture-investment) — Series B
- KT Investment (https://capitalatlas.ai/funds/kt-investment) — Series B
- Shinhan Securities (https://capitalatlas.ai/funds/shinhan-securities) — Series C
- IMM Investment (https://capitalatlas.ai/funds/imm-investment) — Series C
- NH Investment & Securities (https://capitalatlas.ai/funds/nh-investment-securities) — Series C
- LG CNS — Series C
